SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-19-006831
Filing Date
2019-03-07
Accepted
2019-03-07 17:16:25
Documents
4
Effectiveness Date
2019-03-07

Document Format Files

Seq Description Document Type Size
1 S-8 agle-s8.htm S-8 148075
2 EX-5.1 agle-ex51_6.htm EX-5.1 15278
3 EX-23.1 agle-ex231_7.htm EX-23.1 1949
4 EX-99.2 agle-ex992_118.htm EX-99.2 140483
  Complete submission text file 0001564590-19-006831.txt   306850
Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-230137 | Film No.: 19666741
SIC: 2834 Pharmaceutical Preparations